BSE: AUROPHARMA - Aurobindo Pharma Limited

半年間の収益性: -26.84%
配当利回り: 0.00%

プロモーションスケジュール Aurobindo Pharma Limited


会社について Aurobindo Pharma Limited

Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally.

さらに詳しく
The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

ISIN INE406A01037
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.7306
Дивиденд ао 4.5
Сайт https://www.aurobindo.com
Цена ао 1157.1
1日あたりの価格変動: 0% (1082.55)
週ごとの価格変動: -1.15% (1095.1)
月ごとの料金変更: -1.11% (1094.65)
3ヶ月間の価格変動: -6.83% (1161.85)
半年間の価格変動: -26.84% (1479.8)
年間の価格変動: -0.4597% (1087.55)
3年間の価格推移: +55.22% (697.45)
5年間の価格推移: +111.68% (511.4)
年初からの価格変動: -13.81% (1255.95)

過小評価

名前 意味 学年
P/S 2.08 7
P/BV 2 7
P/E 18.84 7
EV/EBITDA 7.61 9
合計: 6.88

効率

名前 意味 学年
ROA, % 7.47 2
ROE, % 11.2 4
合計: 3.17

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0.7143 7.14
合計: 1.52

義務

名前 意味 学年
Debt/EBITDA 1.58 7
合計: 8.4

成長の衝動

名前 意味 学年
収益性 Revenue, % 26.24 4
収益性 Ebitda, % 2.24 1
収益性 EPS, % 12.08 2
合計: 1.8

スーパーバイザー 役職 支払い 生年
Mr. Mettu Madan Mohan Reddy Whole-Time Director 52.35M 1960 (65 年)
Mr. Santhanam Subramanian Chief Financial Officer 21.06M 1961 (64 年)
Mr. Sanjeev Indravadan Dani COO & Head of Formulations N/A 1960 (65 年)
Dr. S. Vijaya Kumar President of Technical N/A 1966 (59 年)
Mr. Arvind Bothra Head of Investor Relations & Corporate Communications N/A
Mr. B. Adi Reddy Compliance Officer & Company Secretary 4.76M
Mr. G. P. Prasad Senior Vice President of Global Finance & Operations N/A
Dr. Sudhir Bimal Singhi Head of Global Finance Operations N/A 1969 (56 年)
Mr. Kambam Nithyananda Reddy Vice Chairman & MD 1958 (67 年)
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. President of Biologics, CEO of Biologics, Vaccines and Peptid & Director 1981 (44 年)

住所: India, Hyderabad, Galaxy Plot No. 1 - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.aurobindo.com